paclitaxel has been researched along with Postpartum Amenorrhea in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hara, F; Iwamoto, T; Mukai, H; Ohashi, Y; Uemura, Y; Watanabe, T | 1 |
| Abramson, V; Albain, KS; Ardman, BM; Bose, R; Briccetti, FM; Burstein, HJ; Cheng, KL; Constantine, M; Dang, CT; DeFusco, PA; DeMeo, MK; Faggen, MG; Forero-Torres, A; Gadi, VK; Hart, LL; Hu, J; Isakoff, SJ; Jankowitz, RC; Kelly Marcom, P; Krop, IE; Liu, MC; Merrill Garrett, A; Mulvey, TM; Nanda, R; Partridge, AH; Pohlmann, PR; Ramaswamy, B; Reeder-Hayes, KE; Rimawi, M; Rosenberg, S; Ruddy, KJ; Rugo, HS; Schneider, BP; Sella, T; Tayob, N; Tolaney, SM; Tung, NM; Valero, VV; Van Poznak, C; Weckstein, DJ; Winer, EP; Wolff, AC; Yardley, DA; Zheng, Y; Zuckerman, DS | 1 |
| Albain, KS; Barry, W; Burstein, HJ; Carey, LA; Dang, CT; Ellis, MJ; Guo, H; Hudis, C; Krop, IE; Marcom, PK; Moy, B; Overmoyer, BA; Partridge, AH; Ruddy, KJ; Rugo, HS; Shapira, I; Tolaney, SM; Winer, EP; Wolff, AC; Yardley, DA | 1 |
| Han, HS; Kang, HS; Kim, SW; Lee, DH; Lee, ES; Lee, H; Lee, KS; Nam, BH; Ro, J; Seo, JA | 1 |
| Abusief, ME; Ginsburg, ES; Missmer, SA; Partridge, AH; Weeks, JC | 1 |
| Carter, WB; Cox, CE; Gross-King, M; Ismail-Khan, R; Lacevic, M; Minton, SE; Moore, AP; Munster, PN; Xu, P | 1 |
| Davis, AL; Klitus, M; Mintzer, DM | 1 |
| Oktay, K; Oktem, O; Reh, A | 1 |
4 trial(s) available for paclitaxel and Postpartum Amenorrhea
| Article | Year |
|---|---|
NSAS-BC02 substudy of chemotherapy-induced amenorrhea (CIA) in premenopausal patients who received either taxane alone or doxorubicin(A) cyclophosphamide(C) followed by taxane as postoperative chemotherapy.
Topics: Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Bridged-Ring Compounds; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Incidence; Lymphatic Metastasis; Mastectomy; Middle Aged; Paclitaxel; Premenopause; Prognosis; Prospective Studies; Receptors, Estrogen; Retrospective Studies; Taxoids; Young Adult | 2020 |
Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial).
Topics: Ado-Trastuzumab Emtansine; Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Maytansine; Middle Aged; Paclitaxel; Receptor, ErbB-2; Trastuzumab; Young Adult | 2021 |
Analysis of chemotherapy-induced amenorrhea rates by three different anthracycline and taxane containing regimens for early breast cancer.
Topics: Adult; Age Factors; Amenorrhea; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Chemotherapy, Adjuvant; Cohort Studies; Cross-Over Studies; Cyclophosphamide; Deoxycytidine; Docetaxel; Doxorubicin; Female; Fluorouracil; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Taxoids | 2009 |
Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer.
Topics: Adult; Amenorrhea; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Fertility; Fluorouracil; Follicle Stimulating Hormone; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Inhibins; Menstruation; Neoadjuvant Therapy; Neoplasm Staging; Ovary; Paclitaxel; Tamoxifen; Time Factors; Treatment Outcome; Triptorelin Pamoate | 2012 |
4 other study(ies) available for paclitaxel and Postpartum Amenorrhea
| Article | Year |
|---|---|
Chemotherapy-related amenorrhea after adjuvant paclitaxel-trastuzumab (APT trial).
Topics: Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase II as Topic; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Grading; Neoplasm Staging; Paclitaxel; Trastuzumab; Tumor Burden | 2015 |
The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women with breast cancer.
Topics: Adult; Amenorrhea; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Middle Aged; Paclitaxel; Premenopause; Trastuzumab | 2010 |
Chemotherapy-induced amenorrhea from adjuvant breast cancer treatment: the effect of the addition of taxanes.
Topics: Adolescent; Adult; Age Factors; Age of Onset; Amenorrhea; Anthracyclines; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Menstruation; Middle Aged; Paclitaxel; Retrospective Studies; Tamoxifen; Taxoids | 2005 |
Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers.
Topics: Adult; Amenorrhea; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Breast Neoplasms; Cyclophosphamide; Estradiol; Female; Follicle Stimulating Hormone; Humans; Infertility, Female; Menstruation; Ovary; Paclitaxel; Prospective Studies; Risk Assessment; Time Factors | 2008 |